Strategic Partnerships There are active partnerships and investments with Mekorot, Israel’s national water company, and multiple news mentions of collaboration. This signals a potential entry point for healthcare water management and public health infrastructure projects, suggesting sales opportunities in water-quality monitoring, early warning systems, and remote health insights integrated with utility operations.

Hospitals to Home The 100% passive urine sensing device mounted in toilets enables remote monitoring and self-monitoring, appealing to both clinical settings for continuous patient data collection and consumer markets seeking at-home chronic condition tracking. Sales opportunities exist in home health programs, senior care facilities, and telemedicine bundles.

Therapeutic Monitoring Biomarker focus includes hydration, pregnancy, kidney stone risk, UTIs, preeclampsia, diabetes indicators, and electrolyte balance. This aligns with value propositions for nephrology, obstetrics, endocrinology, and urology segments, offering cross-sell potential to clinics and insurers for preventive care and early intervention programs.

IoT and AI Enablement Tech stack emphasizes cloud, analytics, and AI-driven urine analysis with wearables integration via WatchOS. This presents opportunities to upsell integration with EHR systems, data analytics platforms, and remote monitoring programs for healthcare providers seeking digital transformation.

Funding and Growth Recent $10M funding, revenue visibility in the low to mid multi-millions, and a lean team indicate a scalable provider with potential for channel partnerships, OEM arrangements, and expanded manufacturing for broader geographic deployment, especially in health-tech and med-tech ecosystems.